Dr. Fechtner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 Harrison Street
Suite L
Syracuse, NY 13202Phone+1 315-464-5253Fax+1 315-464-6333
Education & Training
- University of California (San Diego) Medical CenterFellowship, Glaucoma, 1989 - 1991
- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Ophthalmology, 1986 - 1989
- Tufts Medical CenterFellowship, Glaucoma, 1984 - 1985
- Icahn School of Medicine at Mount SinaiInternship, Transitional Year, 1982 - 1983
- University of Michigan Medical SchoolClass of 1982
- University of Michigan College of Literature, Science and ArtsB.S., Biomedical Science, 1975 - 1979
Certifications & Licensure
- CA State Medical License 1989 - Present
- NY State Medical License 1983 - 2025
- NJ State Medical License 1998 - 2019
- KY State Medical License 1991 - 2002
- MA State Medical License 1984 - 2001
- GA State Medical License 1983 - 1987
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- America's Top Ophthalmologists 2018
- Best Doctors 2018
- New Jersey: Most Recommended Physicians 2010
- Join now to see all
Clinical Trials
- Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery Start of enrollment: 2011 Sep 01
Publications & Presentations
PubMed
- A phase 3 adaptive dose selection trial of NCX 470, a nitric oxide-donating bimatoprost for open-angle glaucoma or ocular hypertension: The MONT BLANC study.Steven L Mansberger, Robert Fechtner, Krisi Lopez, Doug Hubatsch
Contemporary Clinical Trials. 2024-12-01 - A Randomized, Controlled Comparison of NCX 470, a Nitric Oxide-Donating Bimatoprost, and Latanoprost in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The M...Robert Fechtner, Steven Mansberger, James Branch, Jay Mulaney, Sara Ziebell
American Journal of Ophthalmology. 2024-08-01 - 7 citationsA Randomized, Controlled Comparison of NCX 470 (0.021%, 0.042%, and 0.065%) and Latanoprost 0.005% in Patients With Open-angle Glaucoma or Ocular Hypertension: The Dol...Thomas R Walters, Angela C Kothe, José L Boyer, Dale W Usner, Krisol Lopez
Journal of Glaucoma. 2022-06-01
Journal Articles
- Visual Field and Ocular Safety During Short-term Vigabatrin Treatment in Cocaine AbusersBerezina TL, Khouri AS, Winship MD, Fechtner RD, American Journal of Ophthalmology, 8/1/2012
- A Comparison of Active Ingredients and Preservatives Between Brand Name and Generic Topical Glaucoma Medications using Liquid Chromatography-tandem Mass SpectrometryKahook MY, Fechtner RD, Katz LJ, Noecker RJ, Ammar DA, Current Eye Research, 2/1/2012
- 23-Gauge Pars Plana Vitrectomy with Pars Plana Baerveldt Tube Placement for Refractory GlaucomaKolomeyer AM, Fechtner RD, Zarbin MA, Bhagat N, European Journal of Ophthalmology, 1/1/2012
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Does stimulus size affect test-retest reliability for peripheral visual field testing?Berezina TL, Kuriakose C, Khouri AS, Kolomeyer AM, Fechtner RD, Invest Ophthalmol Vis Sci, 1/1/2014
- Long term outcomes of Ex-PRESS glaucoma filtration surgery in African American patients with glaucoma.John AM, Berezina TL, Fechtner RD, Khouri AS, Investigative Ophthalmology and Visual Science, 1/1/2014
- Diode CPC energy parameters during treatment of refractory childhood glaucoma.Ravindraraj L, Fechtner RD, Khouri AS, Investigative Ophthalmology and Visual Science, 1/1/2014
- Join now to see all
Lectures
- "Glaucoma Update" (Invited Faculty)Napa, CA - 9/1/2013
- "Distinguished Visiting Professor"University of Rochester-Flaum Eye Institute, Rochester, NY - 12/1/2012
- Grand Rounds: "Considerations for Successful Glaucoma Surgery"University of Medicine and Dentistry of New Jersey, Newark, NJ - 9/1/2012
- Join now to see all
Other
- Managing Glaucoma: Beyond IntraOcular Pressure-Therapeutics in Clinical Practice and Beyond.Fechtner RD, Supplement to Review of Ophthalmology; CME-Certified Monograph
9/1/2012 - Reducing the Preservative Load in Glaucoma Therapy.Fechtner RD, Advanced Ocular Care
5/1/2011 - Ocular Surface Disease in the Presence of Glaucoma.Fechtner RD, Asbell PA, Kahook MY, Supplement to Glaucoma Today and Advanced Ocular Care; CME-certified monograph
2/1/2011 - Join now to see all
Press Mentions
- Nicox Appoints Robert N. Weinreb, M.D. And Sanjay G. Asrani, M.D. To Its Glaucoma Clinical Advisory BoardJuly 12th, 2021
- Public Service Announcement Stresses the Importance of Being Tested for GlaucomaAugust 3rd, 2017
- Results from Mont Blanc Phase 3 Trial of Nicox’s NCX 470 in Glaucoma Published in the American Journal of OphthalmologyMarch 26th, 2024
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: